What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2020-12-30 compared with 2020-04-01 · 32 added, 55 removed, 11 unchanged (89% of the section changed)

Market for Registrant’s

Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities

Market Price for Equity Securities

Our common stock is quoted on the over the

counter market under the symbol “CLCN.” The following table sets forth the quarterly high and low daily close for our

common stock for the two years ended September 30, 2018 and 2019.

The bids reflect inter dealer prices without adjustments for

retail mark-ups, mark-downs or commissions and may not represent actual transactions.

There is a very limited market for the Company’s

Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities

Price for Equity Securities

common stock is quoted on the over the counter market under the symbol “CLCN.”

The following table sets forth the

quarterly high and low daily close for our common stock for the two years ended September 30, 2019 and 2020.

The bids reflect

inter dealer prices without adjustments for retail mark-ups, mark-downs or commissions and may not represent actual transactions.

There is a very limited market for the Company’s common stock

Year ended September 30, 2019

8 unchanged sentences

Fourth Quarter

The over the counter market does not impose

listing standards or requirements, does not provide automatic trade executions and does not maintain relationships with quoted

A company traded on the over the counter market may face loss of market makers and lack of readily available bid and ask

prices for its stock and may experience a greater spread between the bid and ask price of its stock and a general loss of liquidity

with its stock.

In addition, certain investors have policies against purchasing or holding over the counter market.

volume and the market value of our securities have been, and will continue to be, materially affected by the trading on the over

the counter market.

At March 25, 2020, the

Company had 13,613,430 outstanding shares of common stock and 130 shareholders of record .

Holders of common stock

are entitled to receive dividends as may be declared by the Company’s Board.

The Company’s Board is not restricted

from paying any dividends but is not obligated to declare a dividend.

No dividends have ever been declared, and it is not anticipated

that dividends will be paid in the foreseeable future.

Any indebtedness the Company incurs in the future may also limit its ability

to pay dividends.

Investors should not purchase the Company’s common stock with the expectation of receiving cash dividends.

Recent Sales of Unregistered Securities

On March 21, 2019, the

Company agreed to cancel 260,630 outstanding stock options granted to the former President of the Company in connection with her

terminated employment agreement and grant her 294,778 new options.

On September 30, 2019,

a total of 14,286 shares of common stock were approved to be issued to each Blake Furlow and Gary Herman for the exercise of 14,286

warrants granted in December 2017 in connection with commitment letters provided to the Company for a line of credit.

On September 27, 2019,

the Company issued shares of common stock consistent with its corporate by-laws to each of the members of the Company’s Board

Members for board compensation, as follows:

Blake Furlow –

99,362 shares, Gary Herman –

272,472 shares, Bart Mitchell

112,739 shares and JoyAnn Kenny-Charlton, 272,472 shares.

On September 27, 2019,

the Company issued 566,176 shares of common stock to its former CEO for compensation earned during the year as per his employment

agreement and for the exercise of his warrants granted in connection with his commitment letter.

On September 27, 2019,

the Company issued 166,667 shares of common stock to its former CFO for compensation earned during the year as per his employment

All of the shares were

issued pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended.

Purchase of Equity Securities by the Issuer

and Affiliated Purchasers

We did not purchase any

of our equity securities during the fourth quarter of the fiscal year covered by this report.

over the counter market does not impose listing standards or requirements, does not provide automatic trade executions and does

not maintain relationships with quoted issuers.

A company traded on the over the counter market may face loss of market makers

and lack of readily available bid and ask prices for its stock and may experience a greater spread between the bid and ask price

of its stock and a general loss of liquidity with its stock.

In addition, certain investors have policies against purchasing or

holding over the counter market.

Both trading volume and the market value of our securities have been, and will continue to be,

materially affected by the trading on the over the counter market.

December 21, 2020, the Company had 13,298,310 outstanding shares of common stock and 128 shareholders of record.

of common stock are entitled to receive dividends as may be declared by the Company’s Board.

The Company’s Board is

not restricted from paying any dividends but is not obligated to declare a dividend.

No dividends have ever been declared, and

it is not anticipated that dividends will be paid in the foreseeable future.

Any indebtedness the Company incurs in the future

may also limit its ability to pay dividends.

Investors should not purchase the Company’s common stock with the expectation

of receiving cash dividends.

Sales of Unregistered Securities

did not issue any securities in unregistered transactions during the fourth quarter of the fiscal year covered by this report.

of Equity Securities by the Issuer and Affiliated Purchasers

did not repurchase any securities in the fourth quarter of the fiscal year covered by this report.

Selected Financial Data

As a smaller reporting company, we are not required

to provide the information required by this Item.

a smaller reporting company, we are not required to provide the information required by this Item.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity